ADIM
COR icon

Alpha DNA Investment Management’s Cencora COR Stock Holding History

Alpha DNA Investment Management’s Portfolio COR Stock Details COR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,596
Closed -$808K – 48
2024
Q4 		$808K Buy
+3,596
New +$846K 0.31% 67
2024
Q2 		– Sell
-3,972
Closed -$965K – 211
2024
Q1 		$965K Buy
+3,972
New +$913K 0.36% 53

Other funds holding COR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's COR Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Cencora (COR) in Q1 2025, closing a stake of 3,596 shares — an estimated $808K sold.

Alpha DNA Investment Management first reported a position in COR in Q1 2024 and held it in 2 quarters. The position peaked at $965K in Q1 2024. 1,291 funds tracked by Wall St. Rank hold COR as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Cencora position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,596 Cencora shares in Q1 2025, an estimated $808K.
  • Alpha DNA Investment Management first reported a position in Cencora in Q1 2024 and held it in 2 quarters.
  • Alpha DNA Investment Management's Cencora position peaked at $965K in Q1 2024.
  • 1,291 funds tracked by Wall St. Rank held Cencora as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.